Issues in T-helper 1 development - Resolved and unresolved

Immunological Reviews

Volumn 202, Issue , 2004, Pages 157-174

  Berenson, Lisa S ^a   Ota, Naruhisa ^a   Murphy, Kenneth M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT PROTEIN; STAT4 PROTEIN;

ANTIGEN PRESENTING CELL; CELL FUNCTION; CELL MATURATION; CELL POLARITY; CELL TYPE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME MECHANISM; GENE ACTIVITY; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; DIMERIZATION; HUMANS; INTERFERON TYPE II; MICE; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TRANSCRIPTION FACTORS;

EID: 9644295708     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.00208.x     Document Type: Review

References (89)

1. + T lymphocytes. Immunol Today 1988;9:268-274.
2. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986:136:2348-2357.
3. + T cells. Ann Rev Immunol 1994;12:635-673.
4. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 1994:12:227-257.
5. Hunter CA, Reiner SL. Cytokines and T cells in host defense. Curr Opin Immunol 2000:12:413-418 [Review].
6. O'Garra A, Murphy K. Role of cytokines in development of Th1 and Th2 cells. Chem Immunol 1996;63:1-13.
7. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000:14:1693-1711.
8. Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol 2002:2:933-944.
9. Chitnis T, Khoury SJ. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol Res 2003:28:223-239.
10. + T-cell subsets in determining transplantation rejection or tolerance. Immunol Rev 2001:182:164-179.
11. Dredge K, Marriott JB, Todryk SM, Dalgleish AG. Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother 2002:51:521-531.
12. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996:383:787-793.
13. Farrar JD, Murphy KM. Type I interferons and T helper development. Immunol Today 2000;21:484-489.
14. Moser M, Murphy KM. Dendritic cell regulation of T(H)1-T(H)2 development. Nat Immunol 2000;1:199-205.
15. Murphy KM, et al. T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases. Curr Top Microbiol Immunol 1999;238:13-26.
16. Murphy KM. T lymphocyte differentiation in the periphery. Curr Opin Immunol 1998;10:226-232.
17. Ouyang W, et al. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998;9:745-755.
18. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997:185:817-824.
19. Nishikomori R, Ehrhardt RO, Strober W. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor beta2 chain expression and signaling. J Exp Med 2000:191:847-858.
20. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993:260:547-549.
21. Heath VL, Showe L, Crain C, Barrat FJ, Trinchieri G, O'Garra A. Cutting edge: ectopic expression of the IL-12 receptor-beta 2 in developing and committed Th2 cells does not affect the production of IL-4 or induce the production of IFN-gamma. J Immunol 2000:164:2861-2865.
22. Nishikomori R, Usui T, Wu CY, Morinobu A, O'Shea JJ, Strober W. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 2002:169:4388-4398.
23. Xu X, Sun YL, Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996:273:794-797.
24. + T cells: evidence for two distinct pathways for promoter activation. Eur J Immunol 1999;29:548-555.
25. Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity 2003;18:415-428.
26. Ouyang W, et al. State-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity 2000:12:27-37.
27. Chang JT, Shevach EM, Segal BM. Regulation of interleukin (IL)-12 receptor beta2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J Exp Med 1999;189:969-978.
28. Smeltz RB, Chen J, Hu-Li J, Shevach EM. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th) 1/Th2 differentiation. Critical downregulatory role of IL-4. J Exp Med 2001:194:143-153.
29. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and Is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 2000:30:1113-1119.
30. Nakahira MT, et al. An absolute requirement for STAT4 and a role for IFN-{gamma} as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex. J Immunol 2001:167:1306-1312.
31. Smeltz RB, Chen J, Ehrhardt R, Shevach EM. Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J Immunol 2002:168:6165-6172.
32. Szabo SJ, Kim ST, Costa GL, Zhang XK, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineagecommitment. Cell 2000:100:655-669.
33. Lee HJ, et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J Exp Med 2000;192:105-115.
34. Mullen AC, et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001;292:1907-1910.
35. Asnagli H, Afkarian M, Murphy KM. Cutting edge: identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human. J Immunol 2002:168:4268-4271.
36. Minegishi N, et al. Alternative promoters regulate transcription of the mouse GATA-2 gene. J Biol Chem 1998;273:3625-3634.
37. Pan X, et al. Identification of human GATA-2 gene distal IS exon and its expression in hematopoietic stem cell fractions. J Biochem 2000:127:105-112.
38. Brewer A, et al. The human and mouse GATA-6 genes utilize two promoters and two initiation codons. J Biol Chem 1999;274:38004-38016.
39. Oosterwegel MA, et al. The role of CTLA-4 in regulating Th2 differentiation. J Immunol 1999:163:2634-2639.
40. Bour-Jordan H, Grogan JL, Tang Q, Auger JA, Locksley RM, Bluestone JA. CTLA-4 regulates the requirement for cytokine-induced signals in T (H) 2 lineage commitment. Nat Immunol 2003:4:182-188.
41. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002:295:338-342.
42. Lighvani AA, et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA 2001:98:15137-15142.
43. + T cells. Nat Immunol 2002;3:549-557.
44. Takeda A, et al. Cutting edge: role of IL-27/ WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003:170:4886-4890.
45. Mullen AC, et al. Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol 2002;3:652-658.
46. Grakoui A, Donermeyer DL, Kanagawa O, Murphy KM, Allen PM. TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization. J Immunol 1999:162:1923-1930.
47. Parronchi P, et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992;149:2977-2983.
48. Hsieh CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992:89:6065-6069.
49. O'Garra A, Macatonia SE, Hsieh CS, Murphy KM. Regulatory role of IL4 and other cytokines in T helper cell development in an alpha beta TCR transgenic mouse system. Res Immunol 1993:144:620-625.
50. + alpha beta-TCR transgenic T cells is macrophage dependent. Int Immunol 1993:5:371-382.
51. Wenner CA, Guler ML, Macatonia SE, O'Garra A, Murphy KM. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J Immunol 1996;156:1442-1447.
52. Rogge L, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997:185:825-831.
53. Leung S, Qureshi SA, Kerr IM, Darnell JEJ, Stark GR. Role of STAT2 in the alpha Interferon signaling pathway. Mol Cell Biol 1995:15:1312-1317.
54. Li X, Leung S, Kerr IM, Stark GR. Functional subdomains of STAT2 required for preassociation with the alpha Interferon receptor and for signaling. Mol Cell Biol 1997:17:2048-2056.
55. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE Jr. Function of Stat2 protein in transcriptional activation by alpha interferon. Mol Cell Biol 1996;16:288-293.
56. Farrar JD, Smith JD, Murphy TL, Murphy KM. Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2. J Biol Chem 2000:275:2693-2697.
57. Farrar JD, Smith JD, Murphy TL, Leung S, Stark GR, Murphy KM. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse STAT2. Nat Immunol 2000;1:65-69.
58. Park C, Lecomte MJ, Schindler C. Murine Stat2 is uncharacteristically divergent. Nucleic Acids Res 1999;27:4191-4199.
59. Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity 2000;13:795-804.
60. Wang J, Pham-Mitchell N, Schindler C, Campbell IL. Dysregulated sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. J Clin Invest 2003:112:535-543.
61. Rogge L, et al. The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998;161:6567-6574.
62. Nguyen BCB, Cousens LP, Doughty LA, Pien GC, Durbin JE, Biron CA. Interferon alpha/ beta-mediated inhibition and promotion of Interferon gamma: STAT1 resolves a paradox. Nat Immunol 2000;1:70-76.
63. Nguyen BCB, et al. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 2002:297:2063-2066.
64. Hilkens CM, Schlaak JF, Kerr IM. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol 2003:171:5255-5263.
65. Athie-Morales V, Smits HH, Cantrell DA, Hilkens CM. Sustained IL-12 signaling is required for Th1 development. J Immunol 2004:172:61-69.
66. Robinson DS, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997;7: 571-581.
67. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM. IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2001;2:157-164.
68. Takekawa M, Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/ MEKK4 MAPKKK. Cell 1998:95:521-530.
69. Rincon M, et al. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998:17:2817-2829.
70. Yu JJ, Tripp CS, Russell JH. Regulation and phenotype of an innate Th1 cell: role of cytokines and the p38 kinase pathway. J Immunol 2003:171:6112-6118.
71. Lu B, Yu H, Chow C, Li B, Zheng W, Davis RJ, Flavell RA. GADD45 gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 2001;14:583-590.
72. Chi H, Lu B, Takekawa M, Davis RJ, Flavell RA. GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells. EMBO J 2004;23: 1576-1586.
73. Lu B, Ferrandino AF, Flavell RA. Gadd45beta is important for perpetuating cognate and inflammatory signals in T cells. Nat Immunol 2004;5:38-44.
74. Yamamoto K, Miura O, Hirosawa S, Miyasaka N. Binding sequence of STAT4: STAT4 complex recognizes the IFN-gamma activation site (GAS)-like sequence (T/A) TTCC(C/G)GGAA(T/A). Biochem Biophys Res Commun 1997;233:126-132.
75. Vinkemeier U, Moarefi I, Darnell JEJ, Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4. Science 1998;279:1048-1052.
76. Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, Darnell JE Jr. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J 1996;15:5616-5626.
77. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE, Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998;93:827-839.
78. Murphy TL, Geissal ED, Farrar JD, Murphy KM. Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation. Mol Cell Biol 2000;20:7121-7131.
79. Ota N, Brett TJ, Murphy TL, Fremont DH, Murphy KM. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat Immunol 2004:5:208-215.
80. Ouyang W, et al. The Ets transcription factor ERM is Th1-specific and induced by IL-12 through a Stat4-dependent pathway. Proc Natl Acad Sci USA 1999;96:3888-3893.
81. Chen X, Bhandari R, Vinkemeier U, Van Den AF, Darnell JE, Kuriyan J. A reinterpretation of the dimerization interface of the N-terminal domains of STATs. Protein Sci 2003;12:361-365.
82. Croze E, Usacheva A, Asarnow D, Minshall RD, Perez HD, Colamonici O. Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type I IFN receptor. J Immunol 2000;165:5127-5132.
83. Usacheva A, Tian X, Sandoval R, Salvi D, Levy D, Colamonici OR. The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex. J Immunol 2003;171:2989-2994.
84. Usacheva A, Kotenko S, Witte MM, Colamonici OR. Two distinct domains within the N-terminal region of Janus kinase 1 interact with cytokine receptors. J Immunol 2002:169:1302-1308.
85. Braunstein J, Brutsaert S, Olson R, Schindler C. STATs dimerize in the absence of phosphorylation. J Biol Chem 2003;278:34133-34140.
86. Stancato LF, David M, Carter-Su C, Larner AC, Pratt WB. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Chem 1996;271:4134-4137.
87. Ndubuisi MI, Guo GG, Fried VA, Etlinger JD, Sehgal PB. Cellular physiology of STAT3: Where's the cytoplasmic monomer? J Biol Chem 1999;274:25499-25509.
88. Meyer T, Gavenis K, Vinkemeier U. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3. Exp Cell Res 2002;272:45-55.
89. Berenson LS, Farrar JD, Murphy TL, Murphy KM. Frontline: Abscence of functional STAT4 activation despite detectable tyrosine phosphorylation induced by murine IFN-alpha. Eur J Immunol 2004;34:2365-2374.